Tracee L. McMiller

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer et al. · New England Journal of Medicine · 2012 · 12.7K citations · Full text

Life Sciences, Immunology, Oncology +17

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

Julie R. Brahmer, Charles G. Drake, Ira Wollner et al. · Journal of Clinical Oncology · 2010 · 2.9K citations · Full text

Medicine, Oncology, Pharmacology +17

Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape

Janis M. Taube, Robert A. Anders, Geoffrey D. Young et al. · Science Translational Medicine · 2012 · 2.1K citations

Life Sciences, Immunology, Oncology +14

Mechanisms regulating PD-L1 expression on tumor and immune cells

Shuming Chen, George A. Crabill, Theresa S. Pritchard et al. · Journal for ImmunoTherapy of Cancer · 2019 · 464 citations · Full text

Medicine, Immunology, Oncology +12

Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade

Janis M. Taube, Geoffrey D. Young, Tracee L. McMiller et al. · Clinical Cancer Research · 2015 · 241 citations · Full text

Medicine, Immunology, Oncology +17